Literature DB >> 30914238

The Future: In Vivo CAR T Cell Gene Therapy.

Rana Mhaidly1, Els Verhoeyen2.   

Abstract

Year:  2019        PMID： 30914238      PMCID： PMC6453545          DOI： 10.1016/j.ymthe.2019.03.012

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

1.  Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors.

Authors:  Qi Zhou; Katharina M Uhlig; Anke Muth; Janine Kimpel; Camille Lévy; Robert C Münch; Janna Seifried; Anett Pfeiffer; Alexandra Trkola; Cheick Coulibaly; Dorothee von Laer; Winfried S Wels; Udo F Hartwig; Els Verhoeyen; Christian J Buchholz
Journal:  J Immunol       Date:  2015-07-31       Impact factor: 5.422

2.  Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.

Authors:  Marco Ruella; Jun Xu; David M Barrett; Joseph A Fraietta; Tyler J Reich; David E Ambrose; Michael Klichinsky; Olga Shestova; Prachi R Patel; Irina Kulikovskaya; Farzana Nazimuddin; Vijay G Bhoj; Elena J Orlando; Terry J Fry; Hans Bitter; Shannon L Maude; Bruce L Levine; Christopher L Nobles; Frederic D Bushman; Regina M Young; John Scholler; Saar I Gill; Carl H June; Stephan A Grupp; Simon F Lacey; J Joseph Melenhorst
Journal:  Nat Med       Date:  2018-10-01       Impact factor: 53.440

Review 3.  Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes.

Authors:  Annika M Frank; Christian J Buchholz
Journal:  Mol Ther Methods Clin Dev       Date:  2018-10-17       Impact factor: 6.698

4.  Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment.

Authors:  Ruben R Bender; Anke Muth; Irene C Schneider; Thorsten Friedel; Jessica Hartmann; Andreas Plückthun; Andrea Maisner; Christian J Buchholz
Journal:  PLoS Pathog       Date:  2016-06-09       Impact factor: 6.823

5.  In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome.

Authors:  Anett Pfeiffer; Frederic B Thalheimer; Sylvia Hartmann; Annika M Frank; Ruben R Bender; Simon Danisch; Caroline Costa; Winfried S Wels; Ute Modlich; Renata Stripecke; Els Verhoeyen; Christian J Buchholz
Journal:  EMBO Mol Med       Date:  2018-11       Impact factor: 12.137

Review 6.  Engineering and Design of Chimeric Antigen Receptors.

Authors:  Sonia Guedan; Hugo Calderon; Avery D Posey; Marcela V Maus
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698
  6 in total
  5 in total

1.  Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors.

Authors:  Annika M Frank; Angela H Braun; Lea Scheib; Shiwani Agarwal; Irene C Schneider; Floriane Fusil; Séverine Perian; Ugur Sahin; Frederic B Thalheimer; Els Verhoeyen; Christian J Buchholz
Journal:  Blood Adv       Date:  2020-11-24

Review 2.  Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.

Authors:  Ying Gong; Roel G J Klein Wolterink; Jianxiang Wang; Gerard M J Bos; Wilfred T V Germeraad
Journal:  J Hematol Oncol       Date:  2021-05-01       Impact factor: 17.388

Review 3.  Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies.

Authors:  Adrien Krug; Adriana Martinez-Turtos; Els Verhoeyen
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

Review 4.  In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy.

Authors:  Tianqing Xin; Li Cheng; Chuchao Zhou; Yimeng Zhao; Zhenhua Hu; Xiaoyan Wu
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

Review 5.  Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.

Authors:  Alejandra Gutierrez-Guerrero; François-Loïc Cosset; Els Verhoeyen
Journal:  Viruses       Date:  2020-09-11       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.